Researcher
Karen Peynshaert
- Keywords:drug delivery barriers, nanomedicine, ocular drug delivery
- Disciplines:Medicinal products, Pharmacognosy and phytochemistry, Pharmaceutics, Other pharmaceutical sciences, Drug discovery and development, Toxicology and toxinology, Pharmacotherapy, Pharmacology, Ophthalmology, In vitro testing, Biopharmaceuticals
Affiliations
- Department of Pharmaceutics (Department)
Member
From27 Sep 2012 → Today
Projects
1 - 7 of 7
- ILM photodisruption: a biophotonic approach to promote retinal ganglion cell engraftment as a cure for blindnessFrom1 Nov 2023 → TodayFunding: FWO senior postdoctoral fellowship
- Postdoctoral Fellowship Program in National Glaucoma Research: "“Exploring ICG-mediated ILM photodisruption as a tool to boost retinal ganglion cell engraftment"From1 Jul 2023 → TodayFunding: Foreign private sponsor - undefined
- Let There Be Light: two biophotonic approaches to boost retinal ganglion cell transplantation as a cure for blindnessFrom1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Toekenning: ARVO Foundation for Eye Research and the Eye Bank Association of America EyeFind Research: "Grant Karen Peynshaert"From1 Feb 2022 → 31 Jan 2023Funding: Foreign Nonprofit organisations and equivalents
- ICG-mediated photoporation of the inner limiting membrane to enhance retinal drug delivery after intravitreal injection.From1 Jan 2020 → 31 Dec 2020Funding: FWO research grant KAN
- Photoporation of the inner limiting membrane to enhance retinal drug delivery after intravitreal injectionFrom1 Oct 2018 → 30 Sep 2022Funding: FWO fellowships
- Nanoparticle-induced autophagy: unraveling the impact on nanoparticle toxicity and therapeutic efficacyFrom1 Jan 2014 → 31 Dec 2017Funding: IWT personal funding - specialisation scholarships
Publications
1 - 10 of 25
- Every nano-step counts : a critical reflection on do’s and don’ts in researching nanomedicines for retinal gene therapy(2023)
Authors: Karen Peynshaert, Joke Devoldere, Katrien Remaut
Pages: 259 - 271 - Laser-induced nanobubbles safely ablate vitreous opacities in vivo(2022)
Authors: Félix Sauvage, Van Phuc Nguyen, Yanxiu Li, Aranit Harizaj, J. Sebag, Dimitri Roels, Viktor Van Havere, Karen Peynshaert, Ranhua Xiong, Juan Fraire, et al.
Pages: 552 - 559 - ICG-mediated photodisruption of the inner limiting membrane enhances retinal drug delivery(2022)
Authors: Karen Peynshaert, Helena Vanluchene, Kaat De Clerck, An-Katrien Minnaert, Morgane Verhoeven, Noémie Gouspillou, Nezahat Bostan, Toshio Hisatomi, Geraldine Accou, Félix Sauvage, et al.
Pages: 315 - 326 - Vaccinia virus protein B18R : influence on mRNA immunogenicity and translation upon non-viral delivery in different ocular cell types(2021)
Authors: An-Katrien Minnaert, Joke Devoldere, Karen Peynshaert, Laure Vercruysse, Katrien Remaut
- Influence of pathogenic stimuli on Müller cell transfection by lipoplexes(2020)
Authors: Karen Peynshaert, Joke Devoldere, Frederik Philips, Fauve Vergauwe, Katrien Remaut
Pages: 87 - 95 - Hyaluronic acid coating of gold nanoparticles for intraocular drug delivery : evaluation of the surface properties and effect on their distribution(2020)
Authors: P. S. Apaolaza, M. Busch, E. Asin-Prieto, Karen Peynshaert, R. Rathod, Katrien Remaut, N. Dünker, A. Göpferich
- Ocular barriers to retinal delivery of intravitreal liposomes : impact of vitreoretinal interface(2020)
Authors: Shirin Tavakoli, Karen Peynshaert, Tatu Lajunen, Joke Devoldere, Eva M. del Amo, Marika Ruponen, Katrien Remaut, Arto Urtti
Pages: 952 - 961 - Morphology and composition of the inner limiting membrane : species-specific variations and relevance toward drug delivery research(2019)
Authors: Karen Peynshaert, Joke Devoldere, An-Katrien Minnaert, Katrien Remaut
Pages: 465 - 475 - Non-viral delivery of chemically modified mRNA to the retina : subretinal versus intravitreal administration(2019)
Authors: Joke Devoldere, Karen Peynshaert, Heleen Dewitte, Christian Vanhove, Lies De Groef, Lieve Moons, Sinem Yilmaz Özcan, Deniz Dalkara, Katrien Remaut
Pages: 315 - 330 - Müller cells as a target for retinal therapy(2019)
Authors: Joke Devoldere, Karen Peynshaert, Katrien Remaut
Pages: 1483 - 1498